0001161697-21-000316.txt : 20210625
0001161697-21-000316.hdr.sgml : 20210625
20210625162516
ACCESSION NUMBER: 0001161697-21-000316
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210624
FILED AS OF DATE: 20210625
DATE AS OF CHANGE: 20210625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Del Carmen Jeffrey
CENTRAL INDEX KEY: 0001816477
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 211048233
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form_4.xml
FORM 4 FOR 06-24-2021
X0306
4
2021-06-24
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001816477
Del Carmen Jeffrey
355 ALHAMBRA CIRCLE
SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
Chief Commercial Officer
Common stock, par value $0.001 per share
2021-06-24
4
M
0
10000
A
10000
D
Common stock, par value $0.001 per share
2021-06-24
4
F
0
2930
D
7070
D
Restricted Stock Units
2021-06-24
4
M
0
10000
0
D
Common Stock
10000
463334
D
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
Derivative securities vest in equal tranches, 1/3rd on June 23, 2021, 1/3rd on June 23, 2022, and 1/3rd on June 23, 2023.
Shares of common stock will be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on June 24, 2021.
/s/ Jeffrey Del Carmen
2021-06-25